Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.
School of Medicine, University of California, San Francisco, San Francisco.
JAMA Neurol. 2022 May 1;79(5):498-508. doi: 10.1001/jamaneurol.2022.0429.
Sleep disturbance is common among patients with neurodegenerative diseases. Examining the subcortical neuronal correlates of sleep disturbances is important to understanding the early-stage sleep neurodegenerative phenomena.
To examine the correlation between the number of important subcortical wake-promoting neurons and clinical sleep phenotypes in patients with Alzheimer disease (AD) or progressive supranuclear palsy (PSP).
DESIGN, SETTING, AND PARTICIPANTS: This longitudinal cohort study enrolled 33 patients with AD, 20 patients with PSP, and 32 healthy individuals from the Memory and Aging Center of the University of California, San Francisco, between August 22, 2008, and December 31, 2020. Participants received electroencephalographic and polysomnographic sleep assessments. Postmortem neuronal analyses of brainstem hypothalamic wake-promoting neurons were performed and were included in the clinicopathological correlation analysis. No eligible participants were excluded from the study.
Electroencephalographic and polysomnographic assessment of sleep and postmortem immunohistological stereological analysis of 3 wake-promoting nuclei (noradrenergic locus coeruleus [LC], orexinergic lateral hypothalamic area [LHA], and histaminergic tuberomammillary nucleus [TMN]).
Nocturnal sleep variables, including total sleep time, sleep maintenance, rapid eye movement (REM) latency, and time spent in REM sleep and stages 1, 2, and 3 of non-REM (NREM1, NREM2, and NREM3, respectively) sleep, and wake after sleep onset. Neurotransmitter, tau, and total neuronal counts of LC, LHA, and TMN.
Among 19 patients included in the clinicopathological correlation analysis, the mean (SD) age at death was 70.53 (7.75) years; 10 patients (52.6%) were female; and all patients were White. After adjusting for primary diagnosis, age, sex, and time between sleep analyses and death, greater numbers of LHA and TMN neurons were correlated with decreased homeostatic sleep drive, as observed by less total sleep time (LHA: r = -0.63; P = .009; TMN: r = -0.62; P = .008), lower sleep maintenance (LHA: r = -0.85; P < .001; TMN: r = -0.78; P < .001), and greater percentage of wake after sleep onset (LHA: r = 0.85; P < .001; TMN: r = 0.78; P < .001). In addition, greater numbers of LHA and TMN neurons were correlated with less NREM2 sleep (LHA: r = -0.76; P < .001; TMN: r = -0.73; P < .001). A greater number of TMN neurons was also correlated with less REM sleep (r = -0.61; P = .01). A greater number of LC neurons was mainly correlated with less total sleep time (r = -0.68; P = .008) and greater REM latency (r = 0.71; P = .006). The AD-predominant group had significantly greater sleep drive, including higher total sleep time (mean [SD], 0.49 [1.18] vs -1.09 [1.37]; P = .03), higher sleep maintenance (mean [SD], 0.18 [1.22] vs -1.53 [1.78]; P = .02), and lower percentage of wake after sleep onset during sleep period time (mean [SD], -0.18 [1.20] vs 1.49 [1.72]; P = .02) than the PSP-predominant group based on unbiased k-means clustering and principal component analyses.
In this cohort study, subcortical wake-promoting neurons were significantly correlated with sleep phenotypes in patients with AD and PSP, suggesting that the loss of wake-promoting neurons among patients with neurodegenerative conditions may disturb the control of sleep-wake homeostasis. These findings suggest that the subcortical system is a primary mechanism associated with sleep disturbances in the early stages of neurodegenerative diseases.
睡眠障碍在神经退行性疾病患者中很常见。研究睡眠障碍的皮质下神经元相关性对于理解早期睡眠神经退行性现象很重要。
检查阿尔茨海默病 (AD) 或进行性核上性麻痹 (PSP) 患者的重要皮质下觉醒促进神经元数量与临床睡眠表型之间的相关性。
设计、地点和参与者:这项纵向队列研究纳入了 2008 年 8 月 22 日至 2020 年 12 月 31 日期间来自加利福尼亚大学旧金山分校记忆与衰老中心的 33 名 AD 患者、20 名 PSP 患者和 32 名健康个体。参与者接受了脑电图和多导睡眠图睡眠评估。对脑桥下丘脑的觉醒促进神经元进行了死后免疫组织化学立体学分析,并纳入临床病理相关性分析。没有符合条件的参与者被排除在研究之外。
睡眠的脑电图和多导睡眠图评估,以及 3 个觉醒核(去甲肾上腺素能蓝斑核 [LC]、食欲素能下丘脑外侧区 [LHA] 和组胺能乳头体核 [TMN])的死后免疫组织化学立体学分析。
夜间睡眠变量,包括总睡眠时间、睡眠维持、快速眼动 (REM) 潜伏期以及 REM 睡眠和非快速眼动 (NREM1、NREM2 和 NREM3) 睡眠的时间,以及睡眠后觉醒。LC、LHA 和 TMN 的神经递质、tau 和总神经元计数。
在 19 名纳入临床病理相关性分析的患者中,死亡时的平均(SD)年龄为 70.53(7.75)岁;10 名患者(52.6%)为女性;所有患者均为白人。调整主要诊断、年龄、性别以及睡眠分析与死亡之间的时间后,LHA 和 TMN 神经元数量的增加与睡眠驱动的稳态减少相关,表现在总睡眠时间减少(LHA:r=-0.63;P=0.009;TMN:r=-0.62;P=0.008)、睡眠维持减少(LHA:r=-0.85;P<0.001;TMN:r=-0.78;P<0.001)和睡眠后觉醒百分比增加(LHA:r=0.85;P<0.001;TMN:r=0.78;P<0.001)。此外,LHA 和 TMN 神经元数量的增加与 NREM2 睡眠减少相关(LHA:r=-0.76;P<0.001;TMN:r=-0.73;P<0.001)。TMN 神经元数量的增加还与 REM 睡眠减少相关(r=-0.61;P=0.01)。TMN 神经元数量的增加与 REM 睡眠潜伏期增加相关(r=0.71;P=0.006)。LC 神经元数量的增加主要与总睡眠时间减少(r=-0.68;P=0.008)和 REM 潜伏期增加(r=0.71;P=0.006)相关。AD 为主组的睡眠驱动明显更高,包括总睡眠时间更高(均值 [标准差],0.49[1.18]比-1.09[1.37];P=0.03)、睡眠维持更高(均值 [标准差],0.18[1.22]比-1.53[1.78];P=0.02)和睡眠期间睡眠后觉醒百分比更低(均值 [标准差],-0.18[1.20]比 1.49[1.72];P=0.02),这是基于无偏 k-均值聚类和主成分分析得出的 PSP 为主组的结果。
在这项队列研究中,皮质下觉醒促进神经元与 AD 和 PSP 患者的睡眠表型显著相关,这表明神经退行性疾病患者中觉醒促进神经元的丧失可能会扰乱睡眠-觉醒的稳态控制。这些发现表明,皮质下系统是神经退行性疾病早期阶段与睡眠障碍相关的主要机制。